STAT+: Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapies

Summary

German autoimmune researcher Georg Schett is co-founding a biotech company focused on developing antibody therapies for autoimmune diseases. Limited details are provided about the company's specific plans or pipeline.